Eli Lilly's tirzepatide (Mounjaro/Zepbound), a dual GIP/GLP-1 receptor agonist, has demonstrated superior weight loss outcomes (approximately 22.5% mean weight reduction in SURMOUNT-1 versus 14.9% for semaglutide), and its accelerating market penetration in the United States is beginning to exert competitive pressure on semaglutide's market share in the weight management segment
Extended symptoms have been classified as probably infection-related (up to 45 weeks), acute post-COVID symptoms (weeks 512), prolonged post-COVID symptoms (weeks 1224), and chronic post-COVID symptoms (more than 24 weeks) [7]
HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the lipoprotein investigators collaborative
Best Practices for Staying on Your Semaglutide Schedule Setting a phone reminder for your injection day removes guesswork and keeps you aligned with your provider's protocol
Sulfur Allergy: What You Need to Know Sulfur Allergy Clarified Many people say they have a sulfur allergy, but true sulfur allergy does not exist
Rotating injection sites is important for all three medications
-(1).png?sfvrsn=c236e848_3)
